Nurix Therapeutics, Inc. - NRIX
About Gravity Analytica
Recent News
- 09.17.2025 - Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis
- 09.17.2025 - Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis
- 09.16.2025 - Stifel 2025 Virtual Immunology and Inflammation Forum
- 09.16.2025 - Stifel 2025 Virtual Immunology and Inflammation Forum
- 09.10.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.10.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.09.2025 - Baird Global Healthcare Congress
- 09.09.2025 - Baird Global Healthcare Congress
- 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
- 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference